$NVRO
NEVRO CORP

2016 Q4 Form 10-Q Financial Statement

#000156459016027982 Filed on November 07, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $70.53M $60.92M $15.40M
YoY Change 112.93% 295.55% 77.69%
Cost Of Revenue $21.70M $19.20M $5.968M
YoY Change 69.53% 221.72% 118.05%
Gross Profit $48.84M $41.69M $9.434M
YoY Change 139.96% 341.88% 59.06%
Gross Profit Margin 69.24% 68.43% 61.25%
Selling, General & Admin $43.80M $35.60M $21.90M
YoY Change 58.7% 62.59% 204.41%
% of Gross Profit 89.68% 85.4% 232.1%
Research & Development $11.30M $7.900M $5.247M
YoY Change 91.53% 50.56% 0.21%
% of Gross Profit 23.14% 18.95% 55.62%
Depreciation & Amortization $490.0K $465.0K $157.0K
YoY Change 53.13% 196.18% 503.85%
% of Gross Profit 1.0% 1.12% 1.66%
Operating Expenses $55.10M $43.60M $27.14M
YoY Change 64.48% 60.63% 118.38%
Operating Profit -$6.269M -$1.872M -$17.71M
YoY Change -52.31% -89.43% 172.53%
Interest Expense -$1.800M -$1.800M $739.0K
YoY Change 260.0% -343.57%
% of Operating Profit
Other Income/Expense, Net -$1.200M $300.0K -$922.0K
YoY Change -132.54% -27.4%
Pretax Income -$9.200M -$3.400M -$19.19M
YoY Change -32.35% -82.28% 147.61%
Income Tax $600.0K $400.0K $269.0K
% Of Pretax Income
Net Earnings -$9.825M -$3.886M -$19.45M
YoY Change -30.77% -80.02% 146.72%
Net Earnings / Revenue -13.93% -6.38% -126.31%
Basic Earnings Per Share
Diluted Earnings Per Share -$340.3K -$136.8K -$698.9K
COMMON SHARES
Basic Shares Outstanding 28.77M 28.55M 27.88M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $276.4M $288.0M $222.6M
YoY Change 42.69% 29.41% 560.55%
Cash & Equivalents $41.41M $42.70M $87.56M
Short-Term Investments $235.0M $245.2M $135.0M
Other Short-Term Assets $5.900M $6.800M $3.500M
YoY Change 47.5% 94.29% 75.0%
Inventory $85.22M $73.40M $42.65M
Prepaid Expenses
Receivables $52.82M $40.80M $10.53M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $420.3M $408.9M $279.2M
YoY Change 48.71% 46.46% 422.06%
LONG-TERM ASSETS
Property, Plant & Equipment $7.132M $7.600M $5.686M
YoY Change 23.09% 33.66% 1867.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.354M $3.300M $1.901M
YoY Change 27.11% 73.59% -7.04%
Total Long-Term Assets $10.29M $11.00M $8.493M
YoY Change 20.35% 29.52% 222.44%
TOTAL ASSETS
Total Short-Term Assets $420.3M $408.9M $279.2M
Total Long-Term Assets $10.29M $11.00M $8.493M
Total Assets $430.6M $419.9M $287.7M
YoY Change 47.87% 45.96% 412.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.16M $13.10M $12.91M
YoY Change -26.16% 1.46% 269.34%
Accrued Expenses $26.03M $19.40M $10.49M
YoY Change 80.99% 84.9% 105.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.20M $34.60M $23.50M
YoY Change 15.96% 47.26% 170.41%
LONG-TERM LIABILITIES
Long-Term Debt $138.1M $136.5M $19.70M
YoY Change 601.22% 592.89%
Other Long-Term Liabilities $1.211M $1.100M $158.0K
YoY Change 162.12% 596.2% 135.82%
Total Long-Term Liabilities $139.4M $137.6M $158.0K
YoY Change 30062.55% 86988.61% 135.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.20M $34.60M $23.50M
Total Long-Term Liabilities $139.4M $137.6M $158.0K
Total Liabilities $181.5M $172.1M $43.34M
YoY Change 220.81% 297.07% 395.01%
SHAREHOLDERS EQUITY
Retained Earnings -$221.2M -$175.2M
YoY Change 16.78% 54.17%
Common Stock $470.9M $419.7M
YoY Change 11.02% 5377.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $249.0M $247.7M $244.3M
YoY Change
Total Liabilities & Shareholders Equity $430.6M $419.9M $287.7M
YoY Change 47.87% 45.96% 412.69%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$9.825M -$3.886M -$19.45M
YoY Change -30.77% -80.02% 146.72%
Depreciation, Depletion And Amortization $490.0K $465.0K $157.0K
YoY Change 53.13% 196.18% 503.85%
Cash From Operating Activities -$15.64M -$1.930M -$29.40M
YoY Change -48.59% -93.44% 324.86%
INVESTING ACTIVITIES
Capital Expenditures -$960.0K -$790.0K -$2.460M
YoY Change 37.14% -67.89% 4000.0%
Acquisitions
YoY Change
Other Investing Activities $10.32M -$6.120M $60.31M
YoY Change -63.7% -110.15% 1135.86%
Cash From Investing Activities $9.360M -$6.910M $57.85M
YoY Change -66.25% -111.94% 1097.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.070M 870.0K 580.0K
YoY Change 126.34% 50.0% -169.88%
NET CHANGE
Cash From Operating Activities -15.64M -1.930M -29.40M
Cash From Investing Activities 9.360M -6.910M 57.85M
Cash From Financing Activities 5.070M 870.0K 580.0K
Net Change In Cash -1.210M -7.970M 29.03M
YoY Change 168.89% -127.45% -1094.18%
FREE CASH FLOW
Cash From Operating Activities -$15.64M -$1.930M -$29.40M
Capital Expenditures -$960.0K -$790.0K -$2.460M
Free Cash Flow -$14.68M -$1.140M -$26.94M
YoY Change -50.61% -95.77% 292.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
106634000
CY2015Q4 us-gaap Inventory Net
InventoryNet
62430000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87036000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22522000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
282631000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5794000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1852000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4009000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
906000
CY2015Q4 us-gaap Assets
Assets
291183000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21887000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14381000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
121000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36389000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
462000
CY2015Q4 us-gaap Liabilities
Liabilities
56591000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-175000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189408000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
234592000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
291183000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
122000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
290000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28143573
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1757000
us-gaap Investment Income Interest
InvestmentIncomeInterest
399000
us-gaap Interest Expense
InterestExpense
2093000
us-gaap Operating Income Loss
OperatingIncomeLoss
-49223000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54848000
us-gaap Operating Expenses
OperatingExpenses
70356000
us-gaap Gross Profit
GrossProfit
21133000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28765282
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
19740000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
424147000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28143573
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15508000
us-gaap Revenues
Revenues
36482000
us-gaap Cost Of Revenue
CostOfRevenue
15349000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2576000
CY2015Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5200000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
245391000
CY2016Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2016Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
175000
CY2016Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
245227000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
958000
CY2016Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
24200000
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
36600000
CY2015Q3 us-gaap Inventory Write Down
InventoryWriteDown
500000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
Limited one- to five-year warranty
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2016Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
269412000
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
176382000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
139691000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
132000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
139823000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2015 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32132000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
37096000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
41235000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
25334000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9543000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6496000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1936000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
702000
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
465000
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
157000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14260000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9857000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
745000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
583000
CY2016Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2033000
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2044000
CY2016Q3 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
642000
CY2015Q4 nvro Accrued Clinical And Research Expenses Current
AccruedClinicalAndResearchExpensesCurrent
405000
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
897000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2806000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1492000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1260000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28547789
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27881302
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28382147
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26126145
CY2016Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
5029
CY2015Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
19779
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
8717
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
23466
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3204472
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2907246
nvro Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M

Files In Submission

Name View Source Status
0001564590-16-027982-index-headers.html Edgar Link pending
0001564590-16-027982-index.html Edgar Link pending
0001564590-16-027982.txt Edgar Link pending
0001564590-16-027982-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvro-10q_20160930.htm Edgar Link pending
nvro-20160930.xml Edgar Link completed
nvro-20160930.xsd Edgar Link pending
nvro-20160930_cal.xml Edgar Link unprocessable
nvro-20160930_def.xml Edgar Link unprocessable
nvro-20160930_lab.xml Edgar Link unprocessable
nvro-20160930_pre.xml Edgar Link unprocessable
nvro-ex102_380.htm Edgar Link pending
nvro-ex311_7.htm Edgar Link pending
nvro-ex312_6.htm Edgar Link pending
nvro-ex321_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending